Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not met a claims data submission policy it implemented on Feb. | The drugmaker has issued a June 8 ultimatum to an unspecified number of hospitals that have resisted a data submission policy it implemented in February. Furious hospital industry groups are pushing back, calling the decision unlawful and urging the administration to intervene.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Eli Lilly issues data sharing ultimatum to 340B hospitals

Lilly gives hospitals deadline to comply with 340B claims data policy

Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts

Pharmalittle: We're reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more

Lilly, Boehringer to slash at least $1B each from planned investments in Germany

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have…

Eli Lilly threatens to cut 340B discounts for hospitals that won't share claims data, as the American Hospital Association calls…

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next…

The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last week.…

Eli Lilly's 340B claims data deadline has passed, but the pharma company isn't saying what's next as hospitals and legal experts…

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a…